CG Health Ventures
VC Fund
Barcelona, Spain
CG Health Ventures is a venture capital firm that seeks to invest in the health IT, digital health and genomics domain.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries CG Health Ventures invests in
Stages CG Health Ventures invests in
Countries CG Health Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Seed
- $549k–$6M
- Series A
- $7.7M–$37M
Investment Focus
Industry
- Health Care 5 (83%)
- Medical 1 (17%)
- Women's 1 (17%)
- mHealth 1 (17%)
- Diabetes 1 (17%)
Stage
- Series A 3 (50%)
- Seed 2 (33%)
- Convertible Note 1 (17%)
Country
- United States 3 (50%)
- Spain 2 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Carlos Gallardo
Founder & Managing Director
|
Founder & Managing Director | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Cercle
|
Cercle advances women's healthcare by unlocking access to insights. Cercle’s platform, the Cercle Biomedical Graph™, transforms healthcare data at scale into real-time, high-quality insights that women's healthcare providers use to run more efficient businesses and provide personalized care. | $6M / Seed / Sep 18, 2024 | |
Amelia Virtual Care
|
Psious develops a virtual reality platform designed to bring value to mental health treatment. The company's platform uses hyper-realistic virtual environments to treat anxiety disorders by means of virtual exposure therapy, enabling professionals to improve mental health therapies. | $7.7M / Series A / Jun 28, 2022 | |
|
Amelia Virtual Care
|
Psious develops a virtual reality platform designed to bring value to mental health treatment. The company's platform uses hyper-realistic virtual environments to treat anxiety disorders by means of virtual exposure therapy, enabling professionals to improve mental health therapies. | $7.4M / Convertible Note / Jun 28, 2022 | |
Babyscripts
|
Babyscripts’ three-tiered approach to virtual maternity care allows providers to deliver risk-specific care to pregnant mothers at any time, in any place. The first tier consists of a digital education layer delivered via a mobile app, with daily gestational-age and practice-specific, customizable content extending through one year postpartum toengage and empower pregnant mothers through trusted resources. The second tier enables virtual management of pregnant patients through the addition of remote monitoring. Depending on the risk, patients are provided with medical devices (like a bluetooth-enabled blood pressure cuff) to monitor for elevated risk, alerting the provider through a unique trigger alert system to enable risk management and intervention. This smart end-to-end management of patients enables the provider to transition care outside of the clinic and address problems of access, allowing them to automate a majority of their patient care while more effectively allocating time and resources to higher-risk patients. The third tier brings the insurer into the equation in a unique collaboration between the care team and payer, solving some of the structural issues of care coordination and access to care, improving outcomes while reducing cost. | $7.7M / Series A / Jul 20, 2017 | |
Virta Health
|
Virta develops treatments to reversing type 2 diabetes without medications or surgery. Among enrolled patients in its clinical trial at one year, 60% achieved diabetes reversal, and 94% of insulin users reduced or eliminated usage altogether. Results extend beyond diabetes reversal to other areas of metabolic and cardiovascular health, withsustained improvements in blood pressure, inflammation, liver function, and BMI. Delivered through Virta’s novel continuous remote care platform, the Virta Treatment provides unparalleled medical and behavioral support and is transforming the lives of people living with type 2 diabetes. Founded in 2014, the company is headquartered in San Francisco, California. | $37M / Series A / Mar 08, 2017 | |
Made of Genes
|
Genomcore is a professional bioinformatics framework with focus on privacy, compliance and collaborative analysis designed for a broad implementation of precision medicine in a clinical context. Made of Genes is a personal genomics service spined-off from Genomcore. | $549K / Seed / Sep 09, 2016 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does CG Health Ventures invest in?
CG Health Ventures invests primarily in Health Care, Medical and Women's startups, most often at Series A and Seed stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is CG Health Ventures's check size?
CG Health Ventures typically joins rounds of $549k–$6M at Seed and $7.7M–$37M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds CG Health Ventures participates in.
How do I contact CG Health Ventures?
Public channels for CG Health Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at CG Health Ventures?
The team at CG Health Ventures includes Carlos Gallardo (Founder & Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
